| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421077A2 Novel pyrazole analogs acting on cannabinoid receptors |
| 05/26/2004 | EP1421074A1 Novel compounds |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421065A1 Hydrazinopeptoids and their uses for treating cancers |
| 05/26/2004 | EP1421057A1 Chemotherapeutic agents |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420824A2 Compound |
| 05/26/2004 | EP1420823A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420809A1 Use of cyclopenta[g]quinazoline derivatives for treating cancer |
| 05/26/2004 | EP1420803A1 Method for amplifying expression from a cell specific promoter |
| 05/26/2004 | EP1420802A1 Increased solubility flavanolignan preparations |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420792A2 Products and drug delivery vehicles |
| 05/26/2004 | EP1420786A2 Methods of inhibiting formation of vascular channels and proliferation using pyridinone derivatives |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420780A2 Cyclopropyl and cyclobutyl epothilone analogs |
| 05/26/2004 | EP1420777A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 05/26/2004 | EP1420775A1 Platinum complexes and their use in cancer treatment |
| 05/26/2004 | EP1420770A1 Photoreactive compounds and compositions |
| 05/26/2004 | EP1420748A2 Peg-modified uricase |
| 05/26/2004 | EP1420747A2 Benzoquinone ansamycins |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1339703B1 A process for the preparation of paclitaxel |
| 05/26/2004 | EP1322315A4 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 05/26/2004 | EP1313499A4 Method for treating the central nervous system by administration of igf structural analogs |
| 05/26/2004 | EP1265612B1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid |
| 05/26/2004 | EP1218402B1 Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1206474B1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/26/2004 | EP1196443B1 Erythropoietin conjugates with polyethylenglycol |
| 05/26/2004 | EP1159296B1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 05/26/2004 | EP1140122B1 Pro-apoptotic agents |
| 05/26/2004 | EP1124815B1 Method for producing luteolin and luteolin derivatives |
| 05/26/2004 | EP1115687B1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity |
| 05/26/2004 | EP1104475B1 C-myc is activated by beta-catenin and tcf-4 |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP0971710B1 Use of chelerythrine and radiation for tumor therapy |
| 05/26/2004 | EP0932410B1 Mistletoe (viscum) extracts |
| 05/26/2004 | EP0929300B1 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 05/26/2004 | EP0915819B1 Illudin analogs useful as antitumor agents |
| 05/26/2004 | EP0888125B1 GLYCOSYLATED IgG ANTIBODIES |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | EP0786253B1 Antitumor composition comprising ascorbic acid and metal complexes of (na)phthalocyanines |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | EP0623346B1 Inhibitor for metastasis of malignant tumor |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1500090A Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1499976A Caloporoside derivatives, methods for prodn. thereof and their use |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/26/2004 | CN1499966A Compsn of norcantharidin with anticancer drugs containing platinum and its usage |
| 05/26/2004 | CN1499927A Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
| 05/26/2004 | CN1498965A Method for preparing elspar modilfied by carbowax |
| 05/26/2004 | CN1498964A Serial recombined gland related virus inducible path of RNAi, and utilized in gene therapy |
| 05/26/2004 | CN1498898A Minor peptide of growth factor receptor KDR of specific combined blood vessel endothelium |
| 05/26/2004 | CN1498894A Variable region gene in heavy chain and light chain of anti Pgp monoclone antibody |
| 05/26/2004 | CN1498889A Salt of gambogicacid class compound, its preparation method, and medication combination with salt as active ingredient |
| 05/26/2004 | CN1498658A Preparation of high-performance noncellular vaccine and usage |
| 05/26/2004 | CN1498653A Extract of 'Sheganguo' and its prepn. method |
| 05/26/2004 | CN1498625A Application of basil polysaccharide for preparing medicine for curing tumour tranferring |
| 05/26/2004 | CN1498623A Glycyrrhizic acid and its derivative used as RANTES inducer |
| 05/26/2004 | CN1151377C Method of diagnosing and treating epithelioma |
| 05/26/2004 | CN1151251C New human-phosphoguanosine reductase, its coding sequence and application |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/26/2004 | CN1151169C Novel antitumor compound philinopside B from striped pseudo-manatee |
| 05/26/2004 | CN1151168C Antisense thio-oligonucleic acid of target protein kinase C-alpha and its medicine composition and application in treating cancer |
| 05/26/2004 | CN1151156C Novel xanthone compounds, their preparation and use as medicament |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151149C Substituted bisindolyl maleimides for inhibition of cell proliferation |
| 05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 05/26/2004 | CN1150943C Immobilized activity stabilized LHRH-antagonist complexes, method for prodn. thereof |
| 05/26/2004 | CN1150934C Qizhen capsule and its preparing process |
| 05/26/2004 | CN1150928C Medicine for curing cancers and its prepn. method |
| 05/26/2004 | CN1150910C Instant bee pollen and its preparing process |
| 05/26/2004 | CN1150905C Nonatungsten trititanium silicate used as antineoplastic medicine |
| 05/26/2004 | CN1150904C Pharmaceutical compositions for oral administration of molecular iodine |
| 05/26/2004 | CN1150896C New medicine use of 6-methoxy-2-2delta 10'-cis-heptadecene-1,4 benzoquinone |
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
| 05/25/2004 | US6740746 Nucleotide sequences coding polypeptide for use in the treatment and detection of of cancer, coronary or cerebrovascular, hypertensive, diabetic, arthritic and vision defects |
| 05/25/2004 | US6740739 Substitutional variants of APO-2 ligand |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740681 Inhibiting angiogenesis and/or inflammation |
| 05/25/2004 | US6740676 Treating diseases controlled by or responsive to retinoic acid |
| 05/25/2004 | US6740675 3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740661 Farnesyl protein transferase inhibitors |
| 05/25/2004 | US6740657 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |